Cartesian Therapeutics Inc (RNAC)
Cost of Revenue
$12.80M
TTM · Period ending: · USD
RNAC Cost of Revenue
Latest reported$12.80Mperiod ending
Latest reported$12.80Mperiod ending
RNAC Cost of Revenue ($0.00 → $12.80M)
Annual cost of revenue
High-resolution chart · PNG
RNAC cost of revenue history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 0 | |
| 0 | |
| 0 | |
| 2,037,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |